Results 41 to 50 of about 28,557 (262)

Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer

open access: yesTumor Biology, 2017
Primary chemotherapy treatment response monitoring in advanced epithelial ovarian cancer (EOC) is currently based on CT-imaging and serum CA125 values. Serum HE4 profile during first line chemotherapy has not been previously studied. We evaluated the HE4
Tuulia Vallius   +6 more
doaj   +1 more source

Hypoxia-Induced Upregulation of HE4 Is Responsible for Resistance to Radiation Therapy of Gastric Cancer

open access: yesMolecular Therapy: Oncolytics, 2019
Upregulation of human epididymis protein 4 (HE4) is often observed in different types of cancers, including gastric cancer (GC), but the association of elevated HE4 level with radiation resistance in GC remains unclear.
Chunwei Peng   +5 more
doaj   +1 more source

The Role of Interleukin 6 (IL6), Cancer Antigen—125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients

open access: yesPLoS ONE, 2023
Introduction A study of tumor resectability in pre-operative patients with advanced epithelial ovarian cancer is required to predict primary surgical benefits accurately.
Syamel Muhammad   +4 more
semanticscholar   +1 more source

Improved early detection of ovarian cancer using longitudinal multimarker models [PDF]

open access: yes, 2019
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the ...
Blyuss, Oleg   +10 more
core   +3 more sources

Diagnostic and prognostic value of HE4 in female patients with primary peritoneal carcinoma

open access: yesThe International Journal of Biological Markers, 2018
Background: HE4 is a useful tumor marker for the diagnosis of ovarian, endometrial, and fallopian tube carcinoma. Aim: The aim of our study was to investigate the value of serum HE4 compared with CA125 in the diagnosis of primary peritoneal carcinoma and
Dong Mi, Yuexiang Zhang
doaj   +1 more source

Serum Human Epididymis Protein 4 as a Prognostic Marker in Cervical Cancer

open access: yesCancer Control, 2022
Objectives The objective is to evaluate the prognostic value of serum human epididymis protein 4 (HE4) as a tumor marker in patients with cervical cancer.
Woo Yeon Hwang MD   +4 more
doaj   +1 more source

HE4 Transcription- and Splice Variants-Specific Expression in Endometrial Cancer and Correlation with Patient Survival [PDF]

open access: yes, 2013
We investigated the HE4 variant-specific expression patterns in various normal tissues as well as in normal and malignant endometrial tissues. The relationships between mRNA variants and age, body weight, or survival are analyzed. ICAT-labeled normal and
Attewell, John   +9 more
core   +2 more sources

Human epididymis protein 4 (HE4) plasma concentration inversely correlates with the improvement of cystic fibrosis lung disease in p.Phe508del-CFTR homozygous cases treated with the CFTR modulator lumacaftor/ivacaftor combination.

open access: yesJournal of Cystic Fibrosis, 2023
BACKGROUND We previously documented that elevated HE4 plasma concentration decreased in people with CF (pwCF) bearing the p.Gly551Asp-CFTR variant in response to CFTR modulator (CFTRm) ivacaftor (IVA), and this level was inversely correlated with the ...
M. Pócsi   +7 more
semanticscholar   +1 more source

Jost Function for Singular Potentials [PDF]

open access: yes, 1999
An exact method for direct calculation of the Jost function and Jost solutions for a repulsive singular potential is presented. Within this method the Schrodinger equation is replaced by an equivalent system of linear first-order differential equations ...
C. V. Sukumar   +19 more
core   +2 more sources

The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population

open access: yesCancers, 2022
Simple Summary Ovarian cancer is the most common cause of death from gynaecological cancer in the UK. Survival is better when the disease is diagnosed early. However, identifying ovarian cancer is challenging because symptoms are non-specific.
Chloe E. Barr   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy